ReviewPathologie (Heidelberg, Germany)2026
[Spitz tumors].
Review in Pathologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpitz tumors constitute a group of melanocytic neoplasms that can still pose a diagnostic challenge in individual cases.
objectiveThis article provides an overview of the current classification of Spitz tumors with a focus on histopathological aspects. MATERIALS AND
methodsThe Spitz nevus and its variants, the atypical Spitz tumor/Spitz melanocytoma, and the Spitz melanoma were examined.
resultsWith the increasing availability of information from histomorphology, immunohistochemistry, and, most recently, molecular pathology, the classification and associated terminology have changed in recent years. DISCUSSION: While pathologists largely agree on the diagnosis of small and "classic" cases of Spitz nevi in children or adolescents, there can be significant differences among pathologists regarding whether a lesion is assessed as benign or malignant in less typical cases. For more complex tumors, immunohistochemical and molecular characteristics provide support, both in distinguishing them from other types of nevi and as an essential basis for the classification of Spitz tumors themselves. Spitz melanoma is considered an intermediate stage in the progression of Spitz tumors. However, there remains a subset of Spitz tumors in which even experienced experts are unable to make a definitive morphological distinction between a nevus and a melanoma.
Indexed as
Identifiers
42778774What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.